CLINICAL_TRIALS
trial_result
· 2014-12-11
Clinical Trial Update: Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease [Phase 1]
Summary
A Phase 1 study evaluating an autologous Neo-Kidney Augment for chronic kidney disease was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tengion | Conditions: Chronic Kidney Disease | Phase 1 | Status: TERMINATED